Alembic Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹1,564.15Cr |
Net Profits | ₹134.71Cr |
Net Profit Margins | 8.61% |
Highlights
Revenue:
Alembic Pharmaceuticals Ltd’s revenue jumped 4.43% since last year same period to ₹1,564.15Cr in the Q1 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 2.87% jump in its revenue since last 3-months.
Net Profits:
Alembic Pharmaceuticals Ltd’s net profit jumped 11.7% since last year same period to ₹134.71Cr in the Q1 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -24.41% fall in its net profits since last 3-months.
Net Profit Margins:
Alembic Pharmaceuticals Ltd’s net profit margin jumped 6.96% since last year same period to 8.61% in the Q1 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -26.52% fall in its net profit margins since last 3-months.
